Skip to main content

Canada's Largest Cannabis LPs Up 26%, On Average, MTD

The implementation of cannabis as a lower risk Schedule III substance in the U.S. would allow foreign companies to begin selling their products there and that possibility has seen Canadian LPs jump dramatically in price.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.